Celcuity Inc. (CELC): Total Liabilities
$366.00M
As of 2025-12-31
$841.00M
As of 2026-06-30
+105.9%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $366.00M | +182.6% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $129.50M | +151.7% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $51.45M | +22.7% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $41.93M | +143.8% | 2024-03-27, Balance as of period end |
| 2021-12-31 | $17.20M | n/m | 2023-03-23, Balance as of period end |
| 2020-12-31 | $1.25M | +27.6% | 2022-03-23, Balance as of period end |
| 2019-12-31 | $983.2K | +44.1% | 2021-02-16, Balance as of period end |
| 2018-12-31 | $682.2K | +18.0% | 2020-03-13, Balance as of period end |
| 2017-12-31 | $578.1K | +29.8% | 2019-03-01, Balance as of period end |
| 2016-12-31 | $445.4K | n/a | 2018-03-15, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Celcuity Inc. (CELC) | 2025-12-31 | $366.00M | +182.6% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $110.13M | -2.2% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $107.68M | +42.8% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $152.55M | +13.6% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $72.98M | +8.4% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $548.36M | -11.7% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $106.81M | +17.6% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $96.44M | -22.3% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.11B | +30.0% |
Compare CELC, CDNA, CSTL, BLLN side by side · Screen every company in Services-Medical Laboratories ↗